(Q41155339)

27 September 2017

1 reference

title

Fosinopril: a reappraisal of its pharmacology and therapeutic efficacy in essential hypertension (English)

1 reference

27 September 2017

A J Wagstaff

1

1 reference

27 September 2017

R Davis

series ordinal

2

1 reference

27 September 2017

D McTavish

series ordinal

3

1 reference

27 September 2017

publication date

1 May 1996

1 reference

27 September 2017

1 reference

27 September 2017

volume

51

1 reference

27 September 2017

issue

5

1 reference

27 September 2017

page(s)

777-791

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199651050-00006

27 September 2017

exact match

0 references

cites work

The Effect of Fosinopril Sodium on Cerebral Blood Flow in Moderate Essential Hypertension

1 reference

12 December 2020

Evaluation of antihypertensive effects of once-a-day isradipine and fosinopril: a double-blind crossover study by means of ambulatory blood pressure monitoring

1 reference

12 December 2020

Single-dose and steady-state pharmacokinetics of fosinopril and fosinoprilat in patients with hepatic impairment

1 reference

12 December 2020

[Treatment of mild and moderate hypertension with fosinopril. Comparison of adverse effects with other antihypertensive agents]

1 reference

12 December 2020

Cough induced by quinapril with resolution after changing to fosinopril

1 reference

12 December 2020

Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition

1 reference

12 December 2020

Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor

1 reference

12 December 2020

Combined versus single effect of fosinopril and hydrochlorothiazide in hypertensive patients

1 reference

12 December 2020

Angiotensin converting enzyme inhibitors and moderate hypertension

1 reference

12 December 2020

A Comparison of the Cough Profile of Fosinopril and Enalapril in Hypertensive Patients with a History of ACE Inhibitor-Associated Cough

1 reference

12 December 2020

Comparison of fosinopril and hydrochlorothiazide in patients with mild to moderate hypertension

1 reference

12 December 2020

The expanding role of angiotensin converting enzyme inhibitors in the management of hypertension.

1 reference

12 December 2020

Disposition of fosinopril sodium in healthy subjects

1 reference

12 December 2020

ACE inhibitors: review of four new agents.

1 reference

12 December 2020

Clinical pharmacokinetics of the newer ACE inhibitors. A review

1 reference

12 December 2020

Antihypertensive effect of fosinopril, a new angiotensin converting enzyme inhibitor: findings of the Fosinopril Study Group II

1 reference

12 December 2020

Immediate and short-term cardiovascular effects of fosinopril, a new angiotensin-converting enzyme inhibitor, in patients with essential hypertension.

1 reference

12 December 2020

Evaluation of the total hepatic function after treatment with fosinopril in hypertensive patients with liver cirrhosis

1 reference

12 December 2020

Pharmacokinetics of fosinopril in patients with various degrees of renal function

1 reference

12 December 2020

Insulin sensitivity in normotensive subjects during angiotensin converting enzyme inhibition with fosinopril.

1 reference

12 December 2020

Selected aspects of ACE inhibitor therapy for patients with renal disease: impact on proteinuria, lipids and potassium

1 reference

12 December 2020

Once-daily fosinopril in the treatment of hypertension

1 reference

12 December 2020

Newer ACE inhibitors. A look at the future

1 reference

12 December 2020

Role of angiotensin in autoregulation of cerebral blood flow.

1 reference

12 December 2020

Effects of fosinopril on cardiac function in patients with hypertension. Radionuclide assessment of left ventricular systolic and diastolic performance

1 reference

12 December 2020

Fosinopril monotherapy: relationship between blood pressure reduction and time of administration

1 reference

12 December 2020

Fosinopril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in essential hypertension

1 reference

12 December 2020

Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure

1 reference

12 December 2020

Post-exercise reduction in blood pressure in hypertensive subjects: effects of angiotensin converting enzyme inhibition

1 reference

12 December 2020

Effects of fosinopril and hydrochlorothiazide on cerebral perfusion in uncomplicated essential hypertension.

1 reference

12 December 2020

[Fosinopril in a daily single dose in mild and moderate hypertension. Brazilian multicenter study]

1 reference

12 December 2020

Fosinopril in the treatment of hypertension: effects on 24h ambulatory blood pressure and on blood pressure response to exercise

1 reference

12 December 2020

The pharmacokinetics and pharmacodynamics of fosinopril in haemodialysis patients

1 reference

12 December 2020

Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators

1 reference

12 December 2020

Angiotensin converting enzyme inhibitors in hypertension: potential problems

1 reference

12 December 2020

Fosinopril pharmacokinetics and pharmacodynamics in chronic ambulatory peritoneal dialysis patients

1 reference

12 December 2020

Comparison of the Steady-State Pharmacokinetics of Fosinopril, Lisinopril and Enalapril in Patients with Chronic Renal Insufficiency

1 reference

12 December 2020

Pharmacokinetics, Safety, and Pharmacologic Effects of Fosinopril Sodium, an Angiotensin-Converting Enzyme Inhibitor in Healthy Subjects

1 reference

12 December 2020

10.2165/00003495-199651050-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

27 September 2017

1039773910

0 references

1 reference